Cocrystal Pharma Inc (COCP)

[joe_techi]

In 2017, we reduced our net loss to $613,000 after applying an income tax benefit and reduced our loss from operations to $8.3 million. In 2016, our net loss was $75 million and our loss from operations was $106 million. The primary differences were a reduction in G&A to $2.4 million from $4.1 million in 2016 and in 2017 we did not suffer any impairment of our in process research and development while in 2016 we incurred a $92 million impairment charge.